{"id":5516,"date":"2017-07-18T10:33:53","date_gmt":"2017-07-18T14:33:53","guid":{"rendered":"http:\/\/blogs.cooperhealth.org\/weeklyrounds\/?p=5516"},"modified":"2017-07-18T10:33:53","modified_gmt":"2017-07-18T14:33:53","slug":"fda-grants-clearance-for-z-medicas-quikclot","status":"publish","type":"post","link":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/","title":{"rendered":"FDA Grants Clearance for Z-Medica\u2019s QuikClot"},"content":{"rendered":"<p>Z-Medica, LLC announces that QuikClot\u00ae Control+\u2122 has been cleared for use by the U.S. Food and Drug Administration (FDA) under the <em>de novo<\/em> classification process and is designated as a Class II medical device.<\/p>\n<p>For those of you who are familiar with TraumaPads, this is the next generation of the product where the active ingredient is bonded to the woven sponge, resulting in easier removal from the abdominal cavity as well as zero chance of kaolin embolization. This marks the first product of its kind with internal indications.<\/p>\n<p>It was data from Cooper University Hospital that the FDA used to make their final determination to grant approval for this product.<\/p>\n<p><a href=\"http:\/\/www.prweb.com\/releases\/2017\/07\/prweb14497741.htm\">Click here<\/a> for the full press release.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Z-Medica, LLC announces that QuikClot\u00ae Control+\u2122 has been cleared for use by the U.S. Food and Drug Administration (FDA) under the de novo classification process and is designated as a Class II medical device. For those of you who are familiar with TraumaPads, this is the next generation of the product where the active ingredient &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-bkerekes","4":"post-5516","6":"format-standard","7":"category-uncategorized"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FDA Grants Clearance for Z-Medica\u2019s QuikClot - Weekly Rounds<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA Grants Clearance for Z-Medica\u2019s QuikClot - Weekly Rounds\" \/>\n<meta property=\"og:description\" content=\"Z-Medica, LLC announces that QuikClot\u00ae Control+\u2122 has been cleared for use by the U.S. Food and Drug Administration (FDA) under the de novo classification process and is designated as a Class II medical device. For those of you who are familiar with TraumaPads, this is the next generation of the product where the active ingredient ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/\" \/>\n<meta property=\"og:site_name\" content=\"Weekly Rounds\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-18T14:33:53+00:00\" \/>\n<meta name=\"author\" content=\"bkerekes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"bkerekes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/\",\"url\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/\",\"name\":\"FDA Grants Clearance for Z-Medica\u2019s QuikClot - Weekly Rounds\",\"isPartOf\":{\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#website\"},\"datePublished\":\"2017-07-18T14:33:53+00:00\",\"author\":{\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/05e7c3bad4be5c522452b9b39fd2f341\"},\"breadcrumb\":{\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA Grants Clearance for Z-Medica\u2019s QuikClot\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#website\",\"url\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/\",\"name\":\"Weekly Rounds\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/05e7c3bad4be5c522452b9b39fd2f341\",\"name\":\"bkerekes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/53c3f72ca67516193e1db2dacc25d600fb40f31a771a362cec834f4c57547a63?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/53c3f72ca67516193e1db2dacc25d600fb40f31a771a362cec834f4c57547a63?s=96&d=mm&r=g\",\"caption\":\"bkerekes\"},\"url\":\"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/author\/bkerekes\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA Grants Clearance for Z-Medica\u2019s QuikClot - Weekly Rounds","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"FDA Grants Clearance for Z-Medica\u2019s QuikClot - Weekly Rounds","og_description":"Z-Medica, LLC announces that QuikClot\u00ae Control+\u2122 has been cleared for use by the U.S. Food and Drug Administration (FDA) under the de novo classification process and is designated as a Class II medical device. For those of you who are familiar with TraumaPads, this is the next generation of the product where the active ingredient ... [Read more...]","og_url":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/","og_site_name":"Weekly Rounds","article_published_time":"2017-07-18T14:33:53+00:00","author":"bkerekes","twitter_card":"summary_large_image","twitter_misc":{"Written by":"bkerekes","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/","url":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/","name":"FDA Grants Clearance for Z-Medica\u2019s QuikClot - Weekly Rounds","isPartOf":{"@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#website"},"datePublished":"2017-07-18T14:33:53+00:00","author":{"@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/05e7c3bad4be5c522452b9b39fd2f341"},"breadcrumb":{"@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/2017\/07\/fda-grants-clearance-for-z-medicas-quikclot\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/"},{"@type":"ListItem","position":2,"name":"FDA Grants Clearance for Z-Medica\u2019s QuikClot"}]},{"@type":"WebSite","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#website","url":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/","name":"Weekly Rounds","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/05e7c3bad4be5c522452b9b39fd2f341","name":"bkerekes","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/53c3f72ca67516193e1db2dacc25d600fb40f31a771a362cec834f4c57547a63?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/53c3f72ca67516193e1db2dacc25d600fb40f31a771a362cec834f4c57547a63?s=96&d=mm&r=g","caption":"bkerekes"},"url":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/author\/bkerekes\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/posts\/5516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/comments?post=5516"}],"version-history":[{"count":1,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/posts\/5516\/revisions"}],"predecessor-version":[{"id":5517,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/posts\/5516\/revisions\/5517"}],"wp:attachment":[{"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/media?parent=5516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/categories?post=5516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/weeklyrounds\/wp-json\/wp\/v2\/tags?post=5516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}